| 000 | 00724nam a2200217zi 4500 | ||
|---|---|---|---|
| 005 | 20200314100531.0 | ||
| 008 | 170628s2012 xxua 000 0 eng d | ||
| 020 | _a9780939459414 | ||
| 035 | _aMX001001950810 | ||
| 040 |
_aUNAMX _bspa _erda _cUNAMX |
||
| 050 | 4 |
_aRS380 _bA53 |
|
| 245 | 0 | 0 | _aAnalytical method validation and transfer for biotechnology products |
| 264 | 1 |
_aBethesda : _bParenteral Drug Association, _c[2012] |
|
| 300 |
_a67 páginas : _bilustraciones |
||
| 490 | 0 |
_aTechnical report ; _vno.57 |
|
| 650 | 4 |
_aBiotecnología farmacéutica _xAdministración de riesgos |
|
| 336 |
_atexto _2rdacontent |
||
| 337 |
_asin medio _2rdamedia |
||
| 338 |
_avolumen _2rdacarrier |
||
| 999 |
_c14545 _d14545 |
||